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A 56 year old man presented with 7 months of fever, breathlessness, cough, and proximal 
muscle weakness with tenderness. His past history was of hypertension. Examination was 
unremarkable apart from peripheral oedema and a new scaly fissured erythematous rash on 
the hands and fingers (Figure 1). Blood tests revealed normocytic anaemia, low total protein, 
raised inflammatory markers (CRP 59 mg/L (normal 0-5 mg/L) and ESR 43 mm/hr (normal 
1-20 mm/hr)) and negative infective screen. Electrocardiogram was normal. Chest 
radiography and subsequent computed tomography showed interstitial lung disease. 
Echocardiography was normal (Movie 1A) but NT-proBNP was very raised at 245pmol/L 
(normal <47 pmol/L, high levels >236pmol/L). 
Conventional cardiovascular magnetic resonance (CMR) showed a small pericardial effusion 
but normal cardiac size and function (Movie 2A). There was no edema or focal fibrosis on 
T2-weighted imaging and late gadolinium enhancement, respectively.  However, using novel 
CMR parametric mapping techniques to assess T1, T2 and the extracellular volume (ECV), 
abnormalities were found - elevated native myocardial T1 (1090ms; normal 968±32ms; 
Figure 2A) using a shortened modified look locker inversion recovery (ShMOLLI) sequence; 
elevated T2 (62ms; normal 52±3ms; Figure 2B) using T2 mapping, and increased ECV at 15 
minutes post contrast administration (0.40; normal 0.25±0.04), the values obtained from 
averaging all size segments on the mid short axis stack, suggesting global myocardial edema. 
Rheumatology review raised the clincial suspicion of antisynthetase syndrome, confirmed by 
a positive anti-PL12 antibody. An RV biopsy showed a mild interstitial cellular infiltrate, no 
vasculitis, no granulomas, and no fibrosis. The patient was treated with oral steroid therapy 
with dramatic clincial improvement. His CMR was repeated 2 months later with all mapping 
parameters returning to normal (T1=994ms, T2=53ms , ECV=0.29)(Figure 2C-D; Movie 
2B), as well as a fall in NT-proBNP to near normal at 53 pmol/L, and normalization of 
inflammatory markers (CRP 2 mg/L, ESR 7mm/hr). 
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Antisynthetase is a rare autoimmune disease where antibodies are generated to the machinery 
of protein synthesis. Autoantibodies to aminoacyl-transfer RNA (tRNA) synthetases 
(antisynthetase antibodies) are implicated in the pathogenesis and correlate with disease 
activity[1].  Multi-system involvement includes interstitial lung disease, myositis, 
arthropathy, fever, Raynaud’s phenomenon, and skin (“mechanic’s hands” – as seen in this 
patient; Figure 1). Cardiac involvement has only previously been described in the right 
ventricle of one patient [2]. The disease can be treated, as here, by immunosuppression.  
CMR has become the gold standard method for the evaluation of myocardial oedema, but 
conventional CMR can miss diffuse, global disease. Here, mapping techniques permitted the 
detection of previously undefined cardiac involvement, manifesting as global myocardial 
edema, providing new insights into the disease and potential methods for diagnosis and 
monitoring therapy in clinical practice. Developments in CMR imaging techniques are 
enabling rapid clinically-feasible parametric mapping [3, 4], as in this case. 
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Figure Legends: 
 
Figure 1. Classic “mechanic’s hands.” 
 
Figure 2. Mapping images in antisynthetase syndrome showing (A) increased myocardial T2 
and (B) elevated native T1, which normalised after 2 months of steroid therapy (C,D). 
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